Zepp Health Corporation
ZEPP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76,761 | $153,148 | $153,942 | $505,566 |
| - Cash | $808,230 | $995,093 | $959,378 | $1,507,765 |
| + Debt | $1,329,378 | $1,386,856 | $1,701,890 | $1,347,465 |
| Enterprise Value | $597,909 | $544,911 | $896,454 | $345,266 |
| Revenue | $1,333,451 | $2,497,513 | $4,215,626 | $6,169,190 |
| % Growth | -46.6% | -40.8% | -31.7% | – |
| Gross Profit | $512,881 | $653,702 | $817,222 | $1,288,738 |
| % Margin | 38.5% | 26.2% | 19.4% | 20.9% |
| EBITDA | -$345,662 | -$142,882 | -$261,426 | $200,803 |
| % Margin | -25.9% | -5.7% | -6.2% | 3.3% |
| Net Income | -$554,133 | -$220,491 | -$293,372 | $136,019 |
| % Margin | -41.6% | -8.8% | -7% | 2.2% |
| EPS Diluted | -136.64 | -7.84 | -10.84 | 5.24 |
| % Growth | -1,642.9% | 27.7% | -306.9% | – |
| Operating Cash Flow | -$24,392 | $42,602 | -$117,114 | -$331,765 |
| Capital Expenditures | -$1,490 | -$1,679 | -$1,474 | -$45,459 |
| Free Cash Flow | -$25,882 | $40,923 | -$118,588 | -$377,224 |